virasootheChickenpox outbreaks are being reported across the country and children who haven't already had this itchy, highly contagious disease have a 90% likelihood of contracting it before adulthood [1].

NHS Choices recommends 'cooling gels' to help relieve itchy chickenpox symptoms [2] and rapid relief in the form of an innovative cooling gel is now available to prescribe. Care ViraSoothe Chickenpox Relief Cooling Gel is listed in the Drug Tariff under section IXa as a class IIa medical device so can be prescribed and reimbursed. The Drug Tariff listing ensures that Care ViraSoothe is also included in the Nurses formulary.

Care ViraSoothe Chickenpox Relief Cooling Gel, contains a breakthrough technology which works through osmosis to cool and hydrate the skin. This helps stop the urge to scratch, reducing the chance of infection and scarring. Care ViraSoothe (from Care - the No.1 brand sold into pharmacy) [3] has been clinically proven to provide relief from chickenpox symptoms with 70% of children reporting relief [4].

Care ViraSoothe available in 50g and 75g tubes is a clear, odourless gel which is suitable for use on children from 6 months and can be used all over the face and body. It is also available to purchase over the counter from pharmacies.

According to a mother writing on "After 3 days of chickenpox, my daughter has been up all night screaming. She has spots everywhere - her eyelids, armpits, ears and  even in her mouth. It's horrendous, my sons never had it this bad. I have just covered her in Care ViraSoothe from the pharmacy. It is brilliant and she is now fast asleep. I cannot describe how relieved I am that she can finally get some much needed sleep plus it's not messy and very easy to apply."

For further information about chickenpox or Care ViraSoothe, visit: or
Enquiries to: 

Care ViraSoothe forms part of the Care range of products for everyday ailments, information about other products in the Care range can be found by  or contact Thornton & Ross on 01484 842217 


3.IMS Volume Data (MAT June 11) and Care Ex-Factory Volume (MAT June 11)
4.An open label study evaluating the efficacy and tolerability of an osmotic hydrogel gel in the management of itching associated with chickenpox, March 2009